C.F.R. » Title 9 » CHAPTER I—ANIMAL AND PLANT HEALTH INSPECTION SERVICE, DEPARTMENT OF AGRICULTURE › SUBCHAPTER E—VIRUSES, SERUMS, TOXINS, AND ANALOGOUS PRODUCTS; ORGANISMS AND VECTORS › PART 113—STANDARD REQUIREMENTS

9 C.F.R. § 113.50

Ingredients of biological products

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

All ingredients used in a licensed biological product shall meet accepted standards of purity and quality; shall be sufficiently nontoxic so that the amount present in the recommended dose of the product shall not be toxic to the recipient; and in the combinations used shall not denature the specific substances in the product below the minimum acceptable potency within the dating period when stored at the recommended temperature.

[38 FR 29889, Oct. 30, 1973]
Notes of Decisions
Cited in 2 cases, 1998–1998 · leading case: prod.liab.rep. (Cch) P 15,330 Richard Symens Joyce Symens v. Smithkline Beecham Corp., Ivan Sjovall v. Smithkline Beecham Corp., 152 F.3d 1050 (8th Cir. 1998).
Sort: Relevance Newest Treatment
prod.liab.rep. (Cch) P 15,330 Richard Symens Joyce Symens v. Smithkline Beecham Corp., Ivan Sjovall v. Smithkline Beecham Corp., 152 F.3d 1050 (8th Cir. 1998). “See 9 C.F.R. §§ 113.50 -.55. APHIS-mandated testing procedures ensure the “purity, safety, potency, and efficacy” of the vaccine.”
Richard Symens v. Smithkline Beecham, No. 98-1055 (8th Cir. Aug. 27, 1998). “See 9 C.F.R. §§ 113.50 -.55. APHIS-mandated testing procedures ensure the “purity, safety, potency, and efficacy” of the vaccine.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.